vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and Upland Software, Inc. (UPLD). Click either name above to swap in a different company.

Upland Software, Inc. is the larger business by last-quarter revenue ($49.3M vs $37.2M, roughly 1.3× Organogenesis Holdings Inc.). On growth, Upland Software, Inc. posted the faster year-over-year revenue change (-27.5% vs -57.1%). Over the past eight quarters, Upland Software, Inc.'s revenue compounded faster (-16.5% CAGR vs -46.5%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Upland Software, Inc. is a global provider of cloud-based enterprise work management solutions. It offers products covering project portfolio management, customer engagement, IT service management, and financial automation, serving businesses of all sizes across North America, Europe, and Asia-Pacific in tech, healthcare, and professional services sectors.

ORGO vs UPLD — Head-to-Head

Bigger by revenue
UPLD
UPLD
1.3× larger
UPLD
$49.3M
$37.2M
ORGO
Growing faster (revenue YoY)
UPLD
UPLD
+29.5% gap
UPLD
-27.5%
-57.1%
ORGO
Faster 2-yr revenue CAGR
UPLD
UPLD
Annualised
UPLD
-16.5%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ORGO
ORGO
UPLD
UPLD
Revenue
$37.2M
$49.3M
Net Profit
Gross Margin
30.8%
76.5%
Operating Margin
-185.1%
14.5%
Net Margin
Revenue YoY
-57.1%
-27.5%
Net Profit YoY
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
UPLD
UPLD
Q1 26
$37.2M
Q4 25
$225.6M
$49.3M
Q3 25
$150.9M
$50.5M
Q2 25
$101.0M
$53.4M
Q1 25
$86.7M
$63.7M
Q4 24
$126.7M
$68.0M
Q3 24
$115.2M
$66.7M
Q2 24
$130.2M
$69.3M
Net Profit
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
$43.7M
Q3 25
$21.6M
$-1.1M
Q2 25
$-9.4M
$-13.0M
Q1 25
$-18.8M
$-25.8M
Q4 24
$7.7M
Q3 24
$12.3M
$-1.7M
Q2 24
$-17.0M
$-11.4M
Gross Margin
ORGO
ORGO
UPLD
UPLD
Q1 26
30.8%
Q4 25
76.5%
Q3 25
76.9%
Q2 25
74.8%
Q1 25
72.6%
71.6%
Q4 24
75.5%
70.8%
Q3 24
76.7%
70.5%
Q2 24
77.6%
70.5%
Operating Margin
ORGO
ORGO
UPLD
UPLD
Q1 26
-185.1%
Q4 25
28.1%
14.5%
Q3 25
13.7%
10.6%
Q2 25
-12.5%
-13.2%
Q1 25
-30.9%
-1.7%
Q4 24
8.1%
-2.9%
Q3 24
5.4%
-5.0%
Q2 24
-10.7%
-7.7%
Net Margin
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
19.4%
Q3 25
14.3%
-2.2%
Q2 25
-9.3%
-24.4%
Q1 25
-21.7%
-40.6%
Q4 24
6.1%
Q3 24
10.7%
-2.6%
Q2 24
-13.1%
-16.5%
EPS (diluted)
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
$0.31
$0.01
Q3 25
$0.11
$-0.09
Q2 25
$-0.10
$-0.51
Q1 25
$-0.17
$-0.97
Q4 24
$0.05
$-0.30
Q3 24
$0.09
$-0.12
Q2 24
$-0.13
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
UPLD
UPLD
Cash + ST InvestmentsLiquidity on hand
$91.4M
$29.4M
Total DebtLower is stronger
$232.4M
Stockholders' EquityBook value
$-48.4M
Total Assets
$520.0M
$413.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
UPLD
UPLD
Q1 26
$91.4M
Q4 25
$93.7M
$29.4M
Q3 25
$63.7M
$22.8M
Q2 25
$73.1M
$41.0M
Q1 25
$110.0M
$33.7M
Q4 24
$135.6M
$56.4M
Q3 24
$94.3M
$59.7M
Q2 24
$89.9M
$232.4M
Total Debt
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
$232.4M
Q3 25
Q2 25
Q1 25
Q4 24
$290.2M
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
$300.1M
$-48.4M
Q3 25
$255.1M
$-47.3M
Q2 25
$233.2M
$-42.4M
Q1 25
$242.9M
$-37.8M
Q4 24
$262.9M
$-18.3M
Q3 24
$278.5M
$907.0K
Q2 24
$263.5M
$6.5M
Total Assets
ORGO
ORGO
UPLD
UPLD
Q1 26
$520.0M
Q4 25
$598.7M
$413.2M
Q3 25
$509.8M
$409.1M
Q2 25
$461.1M
$441.7M
Q1 25
$467.4M
$457.0M
Q4 24
$497.9M
$529.5M
Q3 24
$446.3M
$554.9M
Q2 24
$443.2M
$739.9M
Debt / Equity
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
UPLD
UPLD
Operating Cash FlowLast quarter
$7.3M
Free Cash FlowOCF − Capex
$7.2M
FCF MarginFCF / Revenue
14.7%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$24.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
$39.4M
$7.3M
Q3 25
$3.1M
$6.9M
Q2 25
$-32.9M
$3.3M
Q1 25
$-19.9M
$8.3M
Q4 24
$10.9M
$9.3M
Q3 24
$8.7M
$4.3M
Q2 24
$4.7M
$5.5M
Free Cash Flow
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
$34.8M
$7.2M
Q3 25
$844.0K
$6.7M
Q2 25
$-36.5M
$2.7M
Q1 25
$-23.6M
$7.9M
Q4 24
$7.6M
$9.0M
Q3 24
$6.1M
$4.2M
Q2 24
$2.9M
$5.2M
FCF Margin
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
15.4%
14.7%
Q3 25
0.6%
13.2%
Q2 25
-36.1%
5.0%
Q1 25
-27.2%
12.4%
Q4 24
6.0%
13.3%
Q3 24
5.3%
6.3%
Q2 24
2.2%
7.5%
Capex Intensity
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
2.1%
0.2%
Q3 25
1.5%
0.4%
Q2 25
3.6%
1.2%
Q1 25
4.2%
0.7%
Q4 24
2.7%
0.5%
Q3 24
2.2%
0.2%
Q2 24
1.4%
0.4%
Cash Conversion
ORGO
ORGO
UPLD
UPLD
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons